LBX Pharmacy

About LBX Pharmacy

LBX Pharmacy Chain JSC, formerly known as Laobaixing Pharmacy Chain Joint Stock Company, operates as a prominent pharmaceutical retail chain in China. Founded in 2001 by entrepreneur Mr. Xie Zilong in the Hunan province, the company was established with the mission to make healthcare affordable. It pioneered the low-price, open-shelf supermarket model for pharmacies in the country. A significant milestone in its history was the strategic investment from EQT Greater China II in 2008, which acquired a co-control stake and helped the company to integrate along the value chain and implement best practices in management and operations. The company was listed on the Shanghai Stock Exchange on April 23, 2015. Subsequent strategic investments were made by Primavera Capital and FountainVest Partners in 2019.

The company's business is segmented into retail, wholesale, and other business activities, including pharmaceutical manufacturing. The core of its operation is the retail segment, which involves selling a wide array of products directly to consumers through its extensive network of stores. Its product mix includes proprietary Chinese and Western medicines, traditional Chinese medicine, health foods, personal care products, and medical equipment. The business model relies on a combination of directly-operated and franchised stores, enabling rapid market expansion. Revenue is generated primarily through the retail and wholesale of these goods. LBX serves the general public across 18 to 22 provinces in China, with a significant presence in markets like Hunan, Jiangsu, and Zhejiang.

LBX Pharmacy operates a vast network of over 15,000 stores, comprising both self-owned and franchised locations, and employs nearly 60,000 people. A key feature of their service is the in-store consultation provided by over 10,000 licensed pharmacists, which enhances customer engagement. The company has also developed a robust membership program to foster customer loyalty. To cater to diverse needs, LBX offers specialized services like a dedicated section for rare drugs and a purchasing service for scarce medications. Embracing digital transformation, the company has ventured into an online-to-offline business model, DTP (Direct-to-Patient) specialty pharmacies, and Chinese medicine store chains to capture new growth opportunities.